Literature DB >> 22508856

Members of the Francisella tularensis phagosomal transporter subfamily of major facilitator superfamily transporters are critical for pathogenesis.

Mark E Marohn1, Araceli E Santiago, Kari Ann Shirey, Michael Lipsky, Stefanie N Vogel, Eileen M Barry.   

Abstract

Francisella tularensis is the causative agent of tularemia. Due to its aerosolizable nature and low infectious dose, F. tularensis is classified as a category A select agent and, therefore, is a priority for vaccine development. Survival and replication in macrophages and other cell types are critical to F. tularensis pathogenesis, and impaired intracellular survival has been linked to a reduction in virulence. The F. tularensis genome is predicted to encode 31 major facilitator superfamily (MFS) transporters, and the nine-member Francisella phagosomal transporter (Fpt) subfamily possesses homology with virulence factors in other intracellular pathogens. We hypothesized that these MFS transporters may play an important role in F. tularensis pathogenesis and serve as good targets for attenuation and vaccine development. Here we show altered intracellular replication kinetics and attenuation of virulence in mice infected with three of the nine Fpt mutant strains compared with wild-type (WT) F. tularensis LVS. The vaccination of mice with these mutant strains was protective against a lethal intraperitoneal challenge. Additionally, we observed pronounced differences in cytokine profiles in the livers of mutant-infected mice, suggesting that alterations in in vivo cytokine responses are a major contributor to the attenuation observed for these mutant strains. These results confirm that this subset of MFS transporters plays an important role in the pathogenesis of F. tularensis and suggest that a focus on the development of attenuated Fpt subfamily MFS transporter mutants is a viable strategy toward the development of an efficacious vaccine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22508856      PMCID: PMC3416476          DOI: 10.1128/IAI.00144-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

Review 1.  Ins and outs of major facilitator superfamily antiporters.

Authors:  Christopher J Law; Peter C Maloney; Da-Neng Wang
Journal:  Annu Rev Microbiol       Date:  2008       Impact factor: 15.500

2.  Aerogenic immunization of man with live Tularemia vaccine.

Authors:  R B Hornick; H T Eigelsbach
Journal:  Bacteriol Rev       Date:  1966-09

3.  Genetic modification of the O-polysaccharide of Francisella tularensis results in an avirulent live attenuated vaccine.

Authors:  Tae-Hyun Kim; Jessica T Pinkham; Sara J Heninger; Sabina Chalabaev; Dennis L Kasper
Journal:  J Infect Dis       Date:  2011-10-03       Impact factor: 5.226

4.  Deletion of TolC orthologs in Francisella tularensis identifies roles in multidrug resistance and virulence.

Authors:  Horacio Gil; Gabrielle J Platz; Colin A Forestal; Michael Monfett; Chandra Shekhar Bakshi; Timothy J Sellati; Martha B Furie; Jorge L Benach; David G Thanassi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-14       Impact factor: 11.205

5.  Experimental tularemia in mice challenged by aerosol or intradermally with virulent strains of Francisella tularensis: bacteriologic and histopathologic studies.

Authors:  J Wayne Conlan; Wangxue Chen; Hua Shen; Ann Webb; Rhonda KuoLee
Journal:  Microb Pathog       Date:  2003-05       Impact factor: 3.738

6.  Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization.

Authors:  J Wayne Conlan; Hua Shen; Igor Golovliov; Carl Zingmark; Petra C F Oyston; Wangxue Chen; Robert V House; Anders Sjöstedt
Journal:  Vaccine       Date:  2009-12-16       Impact factor: 3.641

7.  An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.

Authors:  Chandra Shekhar Bakshi; Meenakshi Malik; Manish Mahawar; Girish S Kirimanjeswara; Karsten R O Hazlett; Lance E Palmer; Martha B Furie; Rajendra Singh; J Andres Melendez; Timothy J Sellati; Dennis W Metzger
Journal:  Vaccine       Date:  2008-08-08       Impact factor: 3.641

8.  Initial delay in the immune response to Francisella tularensis is followed by hypercytokinemia characteristic of severe sepsis and correlating with upregulation and release of damage-associated molecular patterns.

Authors:  Chris A Mares; Sandra S Ojeda; Elizabeth G Morris; Qun Li; Judy M Teale
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

9.  Innate immune recognition of francisella tularensis: activation of type-I interferons and the inflammasome.

Authors:  Jonathan Wiley Jones; Petr Broz; Denise M Monack
Journal:  Front Microbiol       Date:  2011-02-03       Impact factor: 5.640

10.  Identification of transposon insertion mutants of Francisella tularensis tularensis strain Schu S4 deficient in intracellular replication in the hepatic cell line HepG2.

Authors:  Aiping Qin; Barbara J Mann
Journal:  BMC Microbiol       Date:  2006-07-31       Impact factor: 3.605

View more
  13 in total

1.  EmrA1 membrane fusion protein of Francisella tularensis LVS is required for resistance to oxidative stress, intramacrophage survival and virulence in mice.

Authors:  Zhuo Ma; Sukalyani Banik; Harshita Rane; Vanessa T Mora; Seham M Rabadi; Christopher R Doyle; David G Thanassi; Chandra Shekhar Bakshi; Meenakshi Malik
Journal:  Mol Microbiol       Date:  2014-02-08       Impact factor: 3.501

2.  Importance of branched-chain amino acid utilization in Francisella intracellular adaptation.

Authors:  Gael Gesbert; Elodie Ramond; Fabiola Tros; Julien Dairou; Eric Frapy; Monique Barel; Alain Charbit
Journal:  Infect Immun       Date:  2014-10-20       Impact factor: 3.441

3.  Characterization of a Unique Outer Membrane Protein Required for Oxidative Stress Resistance and Virulence of Francisella tularensis.

Authors:  Maha Alqahtani; Zhuo Ma; Harshada Ketkar; Ragavan Varadharajan Suresh; Meenakshi Malik; Chandra Shekhar Bakshi
Journal:  J Bacteriol       Date:  2018-03-26       Impact factor: 3.490

4.  IcgA is a virulence factor of Rhodococcus equi that modulates intracellular growth.

Authors:  Xiaoguang Wang; Garry B Coulson; Aleksandra A Miranda-Casoluengo; Raúl Miranda-Casoluengo; Mary K Hondalus; Wim G Meijer
Journal:  Infect Immun       Date:  2014-02-18       Impact factor: 3.441

Review 5.  Live attenuated tularemia vaccines: recent developments and future goals.

Authors:  Mark E Marohn; Eileen M Barry
Journal:  Vaccine       Date:  2013-06-10       Impact factor: 3.641

6.  Using host-pathogen protein interactions to identify and characterize Francisella tularensis virulence factors.

Authors:  Anders Wallqvist; Vesna Memišević; Nela Zavaljevski; Rembert Pieper; Seesandra V Rajagopala; Keehwan Kwon; Chenggang Yu; Timothy A Hoover; Jaques Reifman
Journal:  BMC Genomics       Date:  2015-12-29       Impact factor: 3.969

Review 7.  Uncovering the components of the Francisella tularensis virulence stealth strategy.

Authors:  Bradley D Jones; Matthew Faron; Jed A Rasmussen; Joshua R Fletcher
Journal:  Front Cell Infect Microbiol       Date:  2014-03-07       Impact factor: 5.293

Review 8.  The complex amino acid diet of Francisella in infected macrophages.

Authors:  Monique Barel; Elodie Ramond; Gael Gesbert; Alain Charbit
Journal:  Front Cell Infect Microbiol       Date:  2015-02-06       Impact factor: 5.293

Review 9.  Importance of Metabolic Adaptations in Francisella Pathogenesis.

Authors:  Jason Ziveri; Monique Barel; Alain Charbit
Journal:  Front Cell Infect Microbiol       Date:  2017-03-28       Impact factor: 5.293

10.  Molecular characterization of putative virulence determinants in Burkholderia pseudomallei.

Authors:  Suat Moi Puah; S D Puthucheary; Jin Town Wang; Yi Jiun Pan; Kek Heng Chua
Journal:  ScientificWorldJournal       Date:  2014-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.